https://ddn.pluspedia.org/w/index.php?action=history&feed=atom&title=Endocrine_Disruptor 2026-09-06T00:23:04Z Versionsgeschichte dieser Seite in PlusPedia MediaWiki 1.43.3 https://ddn.pluspedia.org/w/index.php?title=Endocrine_Disruptor&diff=34564&oldid=prev 2010-03-09T17:20:22Z

<p>Die Seite wurde neu angelegt: „<a href="/wiki/Datei:Pptpdtjpg1.png" title="Datei:Pptpdtjpg1.png">miniatur|Entstehender Artikel</a> {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; | |- | bgcolor=&quot;#d…“</p> <p><b>Neue Seite</b></p><div>[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]<br /> {| class=&quot;wikitable&quot; |<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Freie Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |&lt;ref name=&quot;PMID18524946&quot;&gt;Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer 15(3):649-56 (2008) PMID 18524946 &lt;/ref&gt;&lt;ref name=&quot;PMID16690810&quot;&gt;Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147(6 Suppl):S56-69 (2006) PMID 16690810 &lt;/ref&gt;&lt;ref name=&quot;PMID16690803&quot;&gt;Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 147(6 Suppl):S43-9 (2006) PMID 16690803 &lt;/ref&gt;&lt;ref name=&quot;PMID16690802&quot;&gt;Endocrine-disrupting chemicals use distinct mechanisms of action to modulate endocrine system function. Endocrinology 147(6 Suppl):S25-32 (2006) PMID 16690802 &lt;/ref&gt;&lt;ref name=&quot;PMID16690801&quot;&gt;Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(6 Suppl):S50-5 (2006) PMID 16690801 &lt;/ref&gt;&lt;ref name=&quot;PMID19211731&quot;&gt;Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J Mol Endocrinol 43(1):1-10 (2009) PMID 19211731 &lt;/ref&gt;&lt;ref name=&quot;PMID16037129&quot;&gt;New modes of action for endocrine-disrupting chemicals. Mol Endocrinol 20(3):475-82 (2006) PMID 16037129 &lt;/ref&gt;&lt;ref name=&quot;PMID18794234&quot;&gt;Molecular imaging, an innovative methodology for whole-body profiling of endocrine disrupter action. Toxicol Sci 106(2):304-11 (2008) PMID 18794234 &lt;/ref&gt;&lt;ref name=&quot;PMID18281716&quot;&gt;Fifteen years after &amp;quot;Wingspread&amp;quot;--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol Sci 105(2):235-59 (2008) PMID 18281716 &lt;/ref&gt;&lt;ref name=&quot;PMID16807284&quot;&gt;The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol Sci 94(1):3-21 (2006) PMID 16807284 &lt;/ref&gt;&lt;ref name=&quot;PMID14677558&quot;&gt;Endocrine disruptors and the obesity epidemic. Toxicol Sci 76(2):247-9 (2003) PMID 14677558 &lt;/ref&gt;&lt;ref name=&quot;PMID12832657&quot;&gt;Endocrine disrupters: the need for a refocused vision. Toxicol Sci 74(2):231-2 (2003) PMID 12832657 &lt;/ref&gt;&lt;ref name=&quot;PMID12730617&quot;&gt;Uncertainties for endocrine disrupters: our view on progress. Toxicol Sci 74(2):245-52 (2003) PMID 12730617 &lt;/ref&gt;&lt;ref name=&quot;PMID12773777&quot;&gt;The effect on sperm production in adult Sprague-Dawley rats exposed by gavage to bisphenol A between postnatal days 91-97. Toxicol Sci 74(1):129-38 (2003) PMID 12773777 &lt;/ref&gt;&lt;ref name=&quot;PMID12075103&quot;&gt;Testing for endocrine disruption: how much is enough? Toxicol Sci 68(1):1-3 (2002) PMID 12075103 &lt;/ref&gt;<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Wichtige Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Medline Suchterm/ Synonyme&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#00dfdf&quot; | &#039;&#039;&#039;Was ist das&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Struktur&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Physiologie&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Knockout&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Transgen&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Mutation&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Polymorphismus&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Genexpression&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Inhibitoren&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Agonisten&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |}<br /> <br /> ----<br /> <br /> == Bibliographie ==<br /> &lt;references /&gt;<br /> <br /> <br /> {{LinkWP_Miniartikel|Txt=Endocrine Disruptor|Link=Endokrine Disruptoren}}</div>

Ossip Groth